MobiHealth News May 14, 2024
Jessica Hagen

The Delaware-based company provides self-insured employers with data and strategies to reduce costs associated with prescription medications.

Truveris, a health technology company focused on decreasing prescription costs for employers and their members, announced it had secured $15 million in Series E investment.

Existing investors Canaan Partners and New Leaf Venture Partners led the round.

WHAT IT DOES

The company provides technology to help employers secure lower drug pricing plans. Its software also allows sponsors to garner data-driven insights to reduce prescription costs, improve pharmacy benefit manager-contract terms and increase medication access.

The funds will be used to support the company’s operational growth.

“There has never been more attention placed on PBM practices and the impact on pharmacy...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Employer, Investments, Pharma, Pharma / Biotech, Trends
High cost of weight loss drugs drives employers to require nutrition counseling, in boost for startups
Study: Why Quick Fixes Don’t Work in Workplace Wellness
How Can Employers Manage Rising Healthcare Costs in 2025?
Google maps the future of AI agents: Five lessons for businesses
The Two Events that Changed U.S. Healthcare for Everyone

Share This Article